Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tan To Cheung

Showing results (131-140 of 298) with videos related to

Pageof 30
Sort By:
Surgical Oncology|September 11, 2019
A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillanceKelvin K Ng, Tan-To Cheung, Herbert H Pang, et al.
Theranostics|August 8, 2018
Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinomaChuan Xing Wu, Xiao Qi Wang, Siu Ho Chok, et al.
Hepatology International|April 13, 2011
Validation of graft and standard liver size predictions in right liver living donor liver transplantationSee Ching Chan, Chung Mau Lo, Kenneth S H Chok, et al.
Oncology|December 22, 2007
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinomaThomas Yau, Pierre Chan, Hilda Wong, et al.
World Journal of Gastrointestinal Oncology|May 2, 2019
Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian populationKa Wing Ma, Wong Hoi She, Albert Chi Yan Chan, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 13, 2012
High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantationTan To Cheung, Kenneth S H Chok, Regina C L Lo, et al.
Asian Journal of Surgery|September 29, 2018
Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinomaKelvin K C Ng, Tan-To Cheung, Tiffany C L Wong, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 27, 2017
A new formula for estimation of standard liver volume using computed tomography-measured body thicknessKa Wing Ma, Kenneth S H Chok, Albert C Y Chan, et al.
World Journal of Hepatology|May 31, 2016
Outcome analysis of management of liver trauma: A 10-year experience at a trauma centerWong Hoi She, Tan To Cheung, Wing Chiu Dai, et al.
Annals of Surgical Oncology|December 21, 2007
Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factorsVincent Wai-To Lam, Kelvin K Ng, Kenneth Siu-Ho Chok, et al.
Pageof 30

Showing results (131-140 of 298) with videos related to

Sort By:
Pageof 30
Surgical Oncology|September 11, 2019
A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillanceKelvin K Ng, Tan-To Cheung, Herbert H Pang, et al.
Theranostics|August 8, 2018
Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinomaChuan Xing Wu, Xiao Qi Wang, Siu Ho Chok, et al.
Hepatology International|April 13, 2011
Validation of graft and standard liver size predictions in right liver living donor liver transplantationSee Ching Chan, Chung Mau Lo, Kenneth S H Chok, et al.
Oncology|December 22, 2007
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinomaThomas Yau, Pierre Chan, Hilda Wong, et al.
World Journal of Gastrointestinal Oncology|May 2, 2019
Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian populationKa Wing Ma, Wong Hoi She, Albert Chi Yan Chan, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 13, 2012
High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantationTan To Cheung, Kenneth S H Chok, Regina C L Lo, et al.
Asian Journal of Surgery|September 29, 2018
Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinomaKelvin K C Ng, Tan-To Cheung, Tiffany C L Wong, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 27, 2017
A new formula for estimation of standard liver volume using computed tomography-measured body thicknessKa Wing Ma, Kenneth S H Chok, Albert C Y Chan, et al.
World Journal of Hepatology|May 31, 2016
Outcome analysis of management of liver trauma: A 10-year experience at a trauma centerWong Hoi She, Tan To Cheung, Wing Chiu Dai, et al.
Annals of Surgical Oncology|December 21, 2007
Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factorsVincent Wai-To Lam, Kelvin K Ng, Kenneth Siu-Ho Chok, et al.
Pageof 30